Design and Realization of Lung Organoid Cultures for COVID-19 Applications

Overview

Journal Biodes Manuf

Specialty Biomedical Engineering

Date 2024 Jul 12

PMID 38993804

Authors

Bing Ren

Tryanni R Chiaravalloti

Nadine L Belony

Diana I Romero

Wenxuan Chai

Christopher Leon

Lizi Wu

Nazarius S Lamango

Ite A Offringa

Yong Huang

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been spreading globally and threatening public health. Advanced models that recapitulate the architecture and functioning of specific tissues and organs are in high demand for COVID-19-related pathology studies and drug screening. Three-dimensional (3D) cultures such as self-assembled and engineered organoid cultures surpass conventional two-dimensional (2D) cultures and animal models with respect to the increased cellular complexity, better human-relevant environment, and reduced cost, thus presenting as promising platforms for understanding viral pathogenesis and developing new therapeutics. This review highlights the recent advances in self-assembled and engineered organoid technologies that are used for COVID-19 studies. The challenges and future perspectives are also discussed.

References

van der Vaart J, Clevers H . Airway organoids as models of human disease. J Intern Med. 2020; 289(5):604-613. DOI: 10.1111/joim.13075. View

van der Vaart J, Lamers M, Haagmans B, Clevers H . Advancing lung organoids for COVID-19 research. Dis Model Mech. 2021; 14(6). PMC: 8272930. DOI: 10.1242/dmm.049060. View

Parihar A, Pandita V, Khan R . 3D printed human organoids: High throughput system for drug screening and testing in current COVID-19 pandemic. Biotechnol Bioeng. 2022; 119(10):2669-2688. DOI: 10.1002/bit.28166. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Kapalczynska M, Kolenda T, Przybyla W, Zajaczkowska M, Teresiak A, Filas V . 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. Arch Med Sci. 2018; 14(4):910-919. PMC: 6040128. DOI: 10.5114/aoms.2016.63743. View

Langhans S . Three-Dimensional Cell Culture Models in Drug Discovery and Drug Repositioning. Front Pharmacol. 2018; 9:6. PMC: 5787088. DOI: 10.3389/fphar.2018.00006. View

Si L, Bai H, Rodas M, Cao W, Oh C, Jiang A . A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021; 5(8):815-829. PMC: 8387338. DOI: 10.1038/s41551-021-00718-9. View

Li Y, Wu Q, Sun X, Shen J, Chen H . Organoids as a Powerful Model for Respiratory Diseases. Stem Cells Int. 2020; 2020:5847876. PMC: 7086445. DOI: 10.1155/2020/5847876. View

Griffith L, Swartz M . Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006; 7(3):211-24. DOI: 10.1038/nrm1858. View

10.

Konar D, Devarasetty M, Yildiz D, Atala A, Murphy S . Lung-On-A-Chip Technologies for Disease Modeling and Drug Development. Biomed Eng Comput Biol. 2016; 7(Suppl 1):17-27. PMC: 4839966. DOI: 10.4137/BECB.S34252. View

11.

Sato T, Vries R, Snippert H, van de Wetering M, Barker N, Stange D . Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262-5. DOI: 10.1038/nature07935. View

12.

Ter Ellen B, Dinesh Kumar N, Bouma E, Troost B, van de Pol D, van der Ende-Metselaar H . Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells. Viruses. 2021; 13(7). PMC: 8309965. DOI: 10.3390/v13071335. View

13.

Munoz-Fontela C, Dowling W, Funnell S, Gsell P, Riveros-Balta A, Albrecht R . Animal models for COVID-19. Nature. 2020; 586(7830):509-515. PMC: 8136862. DOI: 10.1038/s41586-020-2787-6. View

14.

Lamers M, van der Vaart J, Knoops K, Riesebosch S, Breugem T, Mykytyn A . An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. EMBO J. 2020; 40(5):e105912. PMC: 7883112. DOI: 10.15252/embj.2020105912. View

15.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

16.

Deguchi S, Serrano-Aroca A, Tambuwala M, Uhal B, Brufsky A, Takayama K . SARS-CoV-2 research using human pluripotent stem cells and organoids. Stem Cells Transl Med. 2021; 10(11):1491-1499. PMC: 8550698. DOI: 10.1002/sctm.21-0183. View

17.

Plebani R, Bai H, Si L, Li J, Zhang C, Romano M . 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics. Int J Mol Sci. 2022; 23(17). PMC: 9456220. DOI: 10.3390/ijms231710071. View

18.

Zhao X, Li C, Liu X, Chiu M, Wang D, Wei Y . Human Intestinal Organoids Recapitulate Enteric Infections of Enterovirus and Coronavirus. Stem Cell Reports. 2021; 16(3):493-504. PMC: 7940440. DOI: 10.1016/j.stemcr.2021.02.009. View

19.

Tiwari S, Wang S, Smith D, Carlin A, Rana T . Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids. Stem Cell Reports. 2021; 16(3):437-445. PMC: 7879814. DOI: 10.1016/j.stemcr.2021.02.005. View

20.

Tian L, Gao J, Garcia I, Chen H, Castaldi A, Chen Y . Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling. Wiley Interdiscip Rev Dev Biol. 2020; 10(6):e399. DOI: 10.1002/wdev.399. View